In News:

Recently, the Union Minister announced that India’s dedicated Antariksh Venture Capital Fund has achieved steady progress, with the deployment of capital into selected startups scheduled to commence in the first quarter of FY2027. This initiative marks a strategic shift from a purely state-led space program to a vibrant, public-private partnership model, aimed at capturing a larger share of the global space economy.

The Antariksh Venture Capital Fund: Financial Architecture

The fund is designed to bridge the "valley of death" for capital-intensive space startups by providing stable, long-term equity.

• Regulatory Structure: It is a close-ended fund registered with the Securities and Exchange Board of India (SEBI) as a Category II Alternative Investment Fund (AIF).
• Key Stakeholders:
  • Investor: The Indian National Space Promotion and Authorization Centre (IN-SPACe), under the Department of Space.
  • Sponsor: The fund is sponsored by SIDBI Venture Capital Limited, leveraging SIDBI’s expertise in managing professional investment vehicles.
• Investment Mandate: The fund exclusively targets Indian companies operating in the space sector. Crucially, it focuses on firms with a Technology Readiness Level (TRL) of 4 and above, ensuring that investments are directed toward proven concepts moving toward commercialization.

IN-SPACe: The Institutional Catalyst

The Indian National Space Promotion and Authorization Centre (IN-SPACe)serves as the backbone of these reforms. Established as a single-window, independent nodal agency, it functions autonomously under the Department of Space (DOS).

Core Functions:

• Authorization & Supervision: It authorizes and oversees the activities of Non-Governmental Entities (NGEs), including the construction of launch vehicles and satellites.
• Infrastructure Sharing: It facilitates the use of ISRO’s world-class infrastructure and premises by private players.
• Interface Role: Acts as a bridge between the technical expertise of ISRO and the commercial agility of NGEs to optimize India's space resources.

Organizational Structure: The agency operates through three specialized directorates:

1. Promotion Directorate (PD): Focused on market development and startup handholding.
2. Technical Directorate (TD): Handles the technical vetting and support of private projects.
3. Program Management and Authorization Directorate (PMAD): Manages the regulatory and licensing aspects.

Strategic Objectives: Beyond Just Capital

The Antariksh Fund is not merely a financial tool; it is a strategic instrument for Aatmanirbhar Bharat:

• Scaling Operations: It provides the "patient capital" required for startups to transition from prototypes to industrial-scale production.
• Commercialization: Supports the market entry of indigenous technologies like small satellite launch vehicles (SSLVs) and satellite-based internet services.
• Global Ambitions: Aims to increase India’s share in the global space market (currently ~2%) by empowering domestic companies to compete internationally.

In News:

Recently, the Prime Minister of India inaugurated the Samrat Samprati Museum in Gujarat. This developmental milestone, alongside the launch of high-tech semiconductor facilities, highlights a dual focus on India’s "Vikas" (Development) and "Virasat" (Heritage). The museum serves to institutionalize the legacy of a Mauryan ruler often overshadowed by his grandfather, Samrat Ashoka, yet pivotal to the religious geography of ancient India.

Samrat Samprati: The 'Jain Ashoka' (224–215 BC)

Samrat Samprati was the grandson of the Mauryan Emperor Ashoka. While Ashoka is synonymous with the global spread of Buddhism, Samprati is revered for his unparalleled contribution to the expansion of Jainism.

• Historical Identity: In various historical and literary records, he is referred to by names such as Indrapalit, Sangat, and Vigatashok.
• Literary Sources: Detailed accounts of his life and administration are found in prominent Jain ures, including the ‘Sampratikatha’, Hemachandra’s ‘Parishistaparva’, and the ‘Prabhavakcharita’.
• Cultural Expansion: Samprati’s influence was not limited to the Indian subcontinent. Historical traditions suggest he established centers of Jain culture as far west as Iran and Arab countries, marking an early instance of Indian cultural diplomacy.
• Architectural Legacy: Much like Ashoka’s pillars and stupas, Samprati is credited with building thousands of Jain temples across Western and Southern India, earning him the title of the "Jain Ashoka."

Foundational Tenets of Jainism (Sramana Tradition)

To understand Samprati’s patronage, it is essential to analyze the Sramanic roots of Jainism—a tradition that emphasizes asceticism and individual effort over ritualistic orthodoxy.

• The Tirthankara Lineage: Jainism is guided by twenty-four Tirthankaras (Ford-makers), who are believed to have established a path across the ocean of rebirth. While Vardhamana Mahavira was the 24th and most prominent teacher, the religion views its wisdom as eternal and handed down through this lineage.
• The Goal of Liberation: The central objective of Jainism is the attainment of Moksha (Nirvana)—liberation from the cycle of birth and death.

The Triple Gems and Ethical Vows

Jainism prescribes a rigorous ethical code categorized into principles for spiritual progress and rules for daily conduct.

The Triratna (Three Jewels): According to Jainism, liberation is achieved through the harmony of:

1. Samyakdarshana (Right Faith): Conviction in the truth of the teachings.
2. Samyakjnana (Right Knowledge): Clear and precise understanding of reality.
3. Samyakcharita (Right Action): Implementing truth through ethical conduct.

The Panchamahavratas (Five Great Vows): These are the strict ethical guidelines followed by Jain monks (and in a modified form by laypeople):

• Ahimsa: Non-violence (the cornerstone of Samprati’s administration).
• Satya: Truthfulness.
• Asteya: Non-stealing.
• Aparigraha: Non-attachment/Non-hoarding.
• Brahmacharya: Celibacy/Chastity.

In News:

Scientists fear that the USA administration's plan to expand oil drilling in the Gulf of Mexico will push Rice's Whales to extinction.

Biological Profile: The Rice’s Whale (Balaenoptera ricei)

Recognized as a distinct species only in 2021, the Rice’s whale is an evolutionary marvel unique to the waters of North America.

• Taxonomy: Member of the baleen whale family (Balaenopteridae). It was previously misclassified as a sub-population of the Bryde’s whale but was found to be genetically and morphologically distinct.
• Distinctive Features:
  • Identified by three prominent ridges in front of the blowhole.
  • Medium-sized body (up to 41 feet), uniformly dark gray on top with a pale to pinkish belly.
• Endemic Distribution: It is the only whale species that resides year-round in the Gulf of Mexico (often referred to in conservation texts as the Gulf of America). They are typically found in a narrow "core habitat" at depths of 100–400 meters in the northeastern Gulf.
• Diet and Reproduction: They primarily consume silver-rag driftfish and reach sexual maturity late (age 9), reproducing only once every 2 to 3 years, which makes population recovery exceptionally slow.

Major Threats to Survival

The Rice's whale faces a "polycrisis" of anthropogenic threats:

• Oil Spills: The species never fully recovered from the 2010 Deepwater Horizon spill, which contaminated nearly 50% of its habitat and caused a 22% population decline.
• Noise Pollution: Seismic airgun blasting for oil exploration interferes with the whales' low-frequency communication and echolocation, disrupting their ability to find food.
• Vessel Strikes: Because these whales often rest near the surface at night, they are highly susceptible to being struck by high-speed industrial ships.
• Climate Change: Rising sea temperatures affect the distribution of their specialized prey, potentially forcing the whales out of protected areas into busier shipping lanes.

Conservation Status and International Protections

• IUCN Red List: Critically Endangered.
• ESA (USA): Listed as Endangered (though current exemptions threaten this status).
• CITES: Listed under Appendix I (the highest level of protection, prohibiting international trade).
• MMPA (USA): Classified as "Depleted" under the Marine Mammal Protection Act.

In News:

In a significant boost to India’s maritime survey capabilities, the Indian Navy has officially received ‘Sanshodhak’ (Yard 3028), the fourth and final vessel of the Survey Vessel (Large) (SVL) project. This delivery marks the successful completion of a strategic shipbuilding program designed to replace aging platforms with state-of-the-art indigenous technology, reinforcing India's commitment to Aatmanirbhar Bharat.

The SVL Project: Evolution and Fleet

The SVL project was initiated through a contract signed in October 2018 between the Ministry of Defence and Garden Reach Shipbuilders and Engineers (GRSE), Kolkata. The project aimed to modernize the Navy's hydrographic fleet by constructing four large-scale survey ships.

• The Fleet Composition: Sanshodhak joins its three sister ships—INS Sandhayak, INS Nirdeshak, and INS Ikshak, to provide the Navy with a complete quartet of modern survey platforms.
• Etymology: The name ‘Sanshodhak’ translates to ‘Researcher’, a title that reflects the ship's primary function as a high-tech platform for underwater data collection and oceanographic analysis.

Technical Specifications and Indigenization

Designed by the Indian Navy’s Warship Design Bureau, the ship stands as a symbol of domestic engineering prowess.

• Dimensions and Displacement: The vessel measures 110 meters in length and has a displacement of approximately 3,400 tons.
• Propulsion and Speed: It is powered by two diesel engines, enabling the ship to reach speeds in excess of 18 knots.
• Indigenous Content: A standout feature for governance and economy modules is that the ship boasts over 80% indigenous content by cost. This involved collaboration with a vast network of Indian industries and MSMEs, stimulating the domestic defense-industrial ecosystem.

Advanced Capabilities: The "Eyes" of the Ocean

Sanshodhak is equipped with a sophisticated suite of sensors and equipment to map the depths of the Indian Ocean Region (IOR).

• Autonomous Systems: It carries Autonomous Underwater Vehicles (AUVs) and Remotely Operated Vehicles (ROVs), allowing for deep-sea exploration without putting divers at risk.
• Sonar and Imaging: The vessel features Digital Side Scan Sonar for high-resolution underwater imaging and a comprehensive Data Acquisition and Processing System to analyze geophysical data in real-time.
• Positioning: High-precision DGPS long-range positioning systems ensure the vessel can map the seabed with centimeter-level accuracy.

Strategic and Civil Applications

The data collected by Sanshodhak serves a dual-purpose, making it a vital asset for both national security and economic development.

• Hydrographic Surveys: It performs full-scale surveys of coastal and deep-water regions, specifically targeting port and harbor approaches.
• Navigational Safety: By determining critical navigational channels, the ship ensures safe passage for both naval warships and commercial merchant vessels.
• Oceanographic Research: It gathers vital oceanographic and geophysical data essential for understanding climate change, marine biology, and underwater topography.
• Defense and Civil Synergy: While the data is used for naval operations, it is also utilized for maritime trade, environmental research, and supporting the Blue Economy.

In News:

The Indian government intensified its oversight of the pharmaceutical market following a surge in the availability of Glucagon-like peptide-1 (GLP-1) receptor agonists. Originally expensive, patented drugs, the recent expiration of key patents (like Semaglutide) has led to a flood of affordable generic versions. While this democratizes treatment for chronic conditions, it has also triggered a "quiet frenzy" of off-label use for rapid weight loss, prompting the Central Drugs Standard Control Organisation (CDSCO) to conduct nationwide inspections across 49 businesses.

What are GLP-1 Drugs?

GLP-1 receptor agonists are a class of medications that mimic a natural hormone produced in the intestines.

• Mechanism of Action:
  • Insulin Stimulation: They signal the pancreas to release insulin and suppress glucagon in response to rising blood glucose levels.
  • Appetite Regulation: They target the brain’s hypothalamus to regulate satiety (the feeling of fullness).
  • Gastric Emptying: They slow down the movement of food through the stomach, prolonging the sensation of satiety.
• Primary Indications: Developed originally by global giants like Novo Nordisk and Eli Lilly, these are FDA and CDSCO-approved for Type 2 Diabetes mellitus and the medical management of chronic obesity.
• Key Molecules: Semaglutide (oral/injectable), Liraglutide, Tirzepatide, and Dulaglutide.

The "Generic Boom" and Economic Impact

The Indian market for obesity drugs is projected to grow from ?1,500 crore to ?8,000 crore by 2030.

• Price Crash: Leading Indian firms have slashed prices significantlysome by over 50%to as low as ?3,999 per month.
• Market Dynamics: The expiration of patent protection has allowed domestic manufacturers to launch biosimilars and generics, making India a global hub for these "lifestyle-altering" medications.

Regulatory Framework and Government Response

Due to the high risk of misuse, the Government of India has classified these as Preion-Only Medicines.

• Authorized Prescribers: To prevent indiscriminate use, only Endocrinologists, Internal Medicine Specialists, and Cardiologists are authorized to prescribe these drugs.
• Central and State Coordination: The Drug Controller General of India (DCGI), in collaboration with State Drug Controllers, has implemented a three-pronged strategy:
  1. Nationwide Audits: Inspections of online pharmacy warehouses, drug wholesalers, and wellness clinics to check for sales without valid preions.
  2. Ban on Surrogate Advertising: On March 10, 2026, the CDSCO issued a comprehensive advisory prohibiting indirect promotion and misleading advertisements that frame these as "quick-fix" cosmetic solutions.
  3. Post-Marketing Surveillance: The Indian Pharmacopoeia Commission (IPC) has been tasked with compiling bi-monthly reports on "Adverse Events" to monitor long-term safety.

Public Health Risks: Misuse and Side Effects

The trend of viewing GLP-1 drugs as "lifestyle products" rather than clinical medication has raised alarms among the medical fraternity (including the Indian Medical Association).

• Common Side Effects: Nausea, vomiting, diarrhea, and constipation.
• Severe Complications: Rare but serious risks include pancreatitis, kidney injury, gallbladder disease, and delayed gastric emptying (gastroparesis).
• "Ozempic Face": Rapid weight loss leading to facial fat depletion and skin sagging.
• Rebound Effect: Without supervised lifestyle changes, patients often face "rebound weight gain" immediately after discontinuation.